An Urdu-language app to support blood sugar control in type 2 diabetes
Tests UrDiaCare, an Urdu diabetes support app, in adults with type 2 diabetes.
Plain-language title generated from the registry record
Registry title: Effectiveness of UrDiaCare
Key facts
- Where
- Gujranwala, PakistanSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 30 and 70 years old?
Source: NCT07814742, who can take part
Where in Pakistan
- District Headquarter HospitalGujranwala, PakistanNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- National University of Medical Sciences, Pakistan
- Trial code
- NCT07814742
- Record updated
- 21 September 2026
- Original description
The goal of this clinical trial is to learn if UrDiaCare, an Urdu-language diabetes support tool, can help adults with type 2 diabetes manage their Diabetes and improve blood sugar levels. The study will include adults aged 30 to 70 years with type 2 diabetes and higher-than-recommended blood sugar levels. The main question is whether UrDiaCare can lower HbA1c, a blood test that shows average blood sugar levels over the past few months, after four months.Read full original descriptionShow less
Effectiveness of UrDiaCare: A Knowledge-Grounded Urdu Large Language Diabetes Management Application on Glycaemic Control Self Management Among Adults With Type 2 Diabetes in Pakistan: A Randomised Controlled Trial
The goal of this clinical trial is to learn if UrDiaCare, an Urdu-language diabetes support tool, can help adults with type 2 diabetes manage their Diabetes and improve blood sugar levels. The study will include adults aged 30 to 70 years with type 2 diabetes and higher-than-recommended blood sugar levels. The main question is whether UrDiaCare can lower HbA1c, a blood test that shows average blood sugar levels over the past few months, after four months.
Researchers will compare UrDiaCare plus standard diabetes care with standard diabetes care plus a single Urdu educational pamphlet. UrDiaCare provides diabetes self-management education and support through WhatsApp/Android. It uses a fixed, health-professional-reviewed information library and does not provide diagnosis or prescribe treatment.
Inclusion: Adults aged 30-70 years with T2DM confirmed ≥ 6 months (clinical record) and HbA1c ≥ 7.5% at screening; Currently prescribed oral antidiabetic medication(s) for ≥ 3 months; Personal ownership and regular daily use of a functioning smartphone (Android/iOS); Able to read and understand Urdu; Available for the full 4-month study period and willing to provide written informed consent -.
Exclusion: Current insulin therapy (to avoid confounding from differing self-management complexity); Type 1, gestational, or secondary diabetes (e.g., steroid-induced, MODY); Severe, uncorrectable comorbidity likely to materially affect glycemic control or survival within 4 months (e.g., end-stage renal disease, active malignancy, liver failure); Significant cognitive impairment or psychiatric disorder precluding informed consent or technology use; Participation in another diabetes clinical trial within the preceding 3 months; Insufficient Urdu reading proficiency, as the UrDiaCare interface is Urdu-script based.